Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. The Food and Drug Administration (FDA) issued emergency authorization Saturday for a novel coronavirus ...

UNION CITY, Calif. (AP) — Blood analysis systems developer Abaxis Inc. said Wednesday it will receive $17.25 million from medical test maker Cepheid Inc. as part of a patent litigation settlement.

GENEVA and SUNNYVALE, Calif., July 16, 2020 /PRNewswire/ -- The Foundation for Innovative New Diagnostics (FIND) and Cepheid, Inc, announced today the launch of the new Xpert® MTB/XDR* test, which ...

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Cepheid as such a stock due to the following factors: CPHD has an average dollar-volume (as ...

SAN FRANCISCO (MarketWatch) -- Cepheid Inc. on Thursday evening reported a second-quarter loss of $3.6 million, or 9 cents a share, compared with a loss of $3.7 million, or 9 cents a share, last year.

Miller Andrew who is EVP, CFO at CEPHEID INC bought 860 shares at $17.11 per share for a total value of $8,041.70 on July 3, 2013. Following this transaction, the EVP, CFO owned 1,015 shares meaning ...